During the past decade, American Health Network of Indiana, LLC conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 22 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Health Network of Indiana, LLC" #1 sponsor was "Pfizer" with 8 trials, followed by "AstraZeneca" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Health Network of Indiana, LLC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "BioCrossroads" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Indiana University School of Medicine" with 2 trials as a collaborator and "Iqvia Pty Ltd" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "American Health Network of Indiana, LLC" are "Diabetes Mellitus, Type 2" (6 trials), "Alzheimer Disease" (4 trials), "Type 2 Diabetes" (4 trials), "Hyperlipidemia" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "American Health Network of Indiana, LLC" in a lesser frequency.

Most popular intervention types in "American Health Network of Indiana, LLC" are "Drug" (44 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "AC2993" (4 trials), "Ocrelizumab" (3 trials), "Bococizumab (PF-04950615; RN316)" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "American Health Network of Indiana, LLC" are 55 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "American Health Network of Indiana, LLC". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in American Health Network of Indiana, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in American Health Network of Indiana, LLC, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".